Historical record - last NADAC publication: 7/19/2017
Product Information
CEFPODOXIME 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $5.0317 per EA under NDC 65862009601. Its NADAC has been published 193 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the CEFPODOXIME PROXETIL market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862009601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
7/19/2017
Active Ingredients
CEFPODOXIME PROXETILApproval Type
Generic (ANDA)
FDA Application
ANDA065370On Market Since
6/11/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFPODOXIME 200 MG TABLET has been published 193 times since Nov 28, 2013, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.0317 per EA |
|---|---|
| All-time high | $6.9699 (Jan 15, 2014) |
| All-time low | $4.9900 (May 17, 2017) |
| Median price | $6.1080 |
| Average price | $6.0181 |
| Largest weekly change | +19.6% (Oct 19, 2016) |
| Weeks tracked | 193 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFPODOXIME 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPODOXIME 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $5.0317 per EA (NDC 65862009601), effective Aug 2, 2017.
How has the price of CEFPODOXIME 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPODOXIME 200 MG TABLET has declined 19.5%. It has been tracked across 193 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPODOXIME 200 MG TABLET?
Since Nov 28, 2013, the NADAC for CEFPODOXIME 200 MG TABLET has ranged from a low of $4.9900 (May 17, 2017) to a high of $6.9699 (Jan 15, 2014), with a median of $6.1080 per EA.
Are there cheaper alternatives to CEFPODOXIME 200 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CEFPODOXIME 200 MG TABLET, is $1.4255 per EA — about 72% below CEFPODOXIME 200 MG TABLET.
Who manufactures CEFPODOXIME 200 MG TABLET?
CEFPODOXIME 200 MG TABLET (NDC 65862009601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification